Establishment of reference intervals of biochemical analytes for healthy Chinese volunteers during the screening process in clinical pharmacology trials-Reference-Cited by-同舟云学术

Establishment of reference intervals of biochemical analytes for healthy Chinese volunteers during the screening process in clinical pharmacology trials

Published:2020-06-03 Issue:9 Volume:76 Page:1227-1235
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Zhong Ping^ORCID,Chen Huanwen,Luo Xi,Liu Jianfeng

Funder

National Natural Science Foundation of China (NSFC) Grants

Zhejiang Provincial Natural Science Foundation of China Grants

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00228-020-02912-1.pdf

Reference35 articles.

1. Sibille M, Deigat N, Durieu I et al (1999) Laboratory data in healthy volunteers: reference values, reference changes screening and laboratory adverse event limits in phase I clinical trials. Eur J Clin Pharmacol 55:13–19. https://doi.org/10.1007/s002280050586

2. Breithaupt-Groegler K, Coch C, Coenen M et al (2017) Who is a ‘healthy subject’?-consensus results on pivotal eligibility criteria for clinical trials. Eur J Clin Pharmacol 73:409–416. https://doi.org/10.1177/1740774517722130

3. Miller WG, Horowitz GL, Ceriotti F et al (2016) Reference intervals: strengths, weaknesses, and challenges. Clin Chem 62:916–923. https://doi.org/10.1373/clinchem.2016.256511

4. Ozarda Y (2016) Reference intervals: current status, recent developments and future considerations. Biochem Med 26:5–16. https://doi.org/10.11613/BM.2016.001

5. Friedberg RC, Souers R, Wagar EA et al (2007) The origin of reference intervals. Arch Pathol Lab Med 131:348–357. https://doi.org/10.1043/1543-2165(2007)131[348:TOORI]2.0.CO;2